Table 2.
Clinical outcomes of patients undergoing single-level transforaminal lumbar interbody fusion.
| Outcome Measure | Spinal Anesthesia (n = 34) | General Anesthesia (n = 60) a | P a |
| Estimated Blood Loss, mL | 68.2 ± 51.8 | 98.0 ± 112.0 | 0.604 |
| Operating (OR) time, min | 211.0 ± 58.4 | 221.0 ± 114.0 | 0.593 |
| Length of stay, d | 2.38 ± 2.36 | 3.42 ± 2.57 | 0.007 |
| 30-day readmission, n (%) | 0.213 b | ||
| No Readmission | 33 (97.1%) | 54 (90.0%) | |
| Readmission | 1 (2.9%) | 6 (10.0%) | |
| Opioid usage | |||
| Intraoperative MEDD | 75.7 ± 139.0 | 123.0 ± 137.0 | <0.001 |
| 24 h post-op MEDD | 68.7 ± 132.0 | 41.9 ± 36.7 | 0.061 |
Abbreviation: MEDD, morphine milligram equivalent daily dose.
Note: Data presented as mean ± SD unless otherwise noted.
Wilcoxon rank sum test for difference in means unless otherwise noted.
Pearson χ2 test for independence.